🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse

Biological Psychiatry(2020)10.1016/j.biopsych.2020.04.009Source: DataRank Database

Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse is a research paper published in Biological Psychiatry (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (49 grants)OA: greenTopics (24)IDs (PubMed, PMC)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Roselinde H. Kaiser ORCID,Thilo Deckersbach ORCID,Jorge Almeida ORCID,Mary L. Phillips ORCID,Henry W. Chase

Live enrichment

PubMed:32507389 PMC:PMC7529779

National Institute of Mental Health

Grant: R37 MH068376

National Institute of Mental Health

Grant: U01MH092221

National Institute of Mental Health

Grant: U01MH092250

Partners Healthcare

Grant: NCT01407094

Massachusetts General Hospital

Grant: US_7647235

Massachusetts General Hospital

Grant: US_7840419

Massachusetts General Hospital

Grant: US_7983936

Massachusetts General Hospital

Grant: US_8145504

Massachusetts General Hospital

Grant: US_8145505

Massachusetts General Hospital

Grant: US_9540691

Massachusetts General Hospital

Grant: US_9546401

National Institutes of Health

Grant: 3U01MH092250-03S1

Biosignatures of Treatment Remission in Major Depression

Allergan

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R37MH068376-20

Neuroimaging Studies of Reward Processing in Depression

National Institutes of Health

Grant: 3U01MH092221-03S1

Establishing Moderators/Biosignatures of Antidepressant Response- Clinical Care

Forest Research Institute

John Templeton Foundation

National Institute of Diabetes and Digestive and Kidney Diseases

Patient-Centered Outcomes Research Institute

Takeda Pharmaceuticals U.S.A.

Avanir Pharmaceuticals

Dana Foundation

Allergan

Boston University

Brain and Behavior Research Foundation

Johnson and Johnson

Massachusetts Medical Society

National Alliance for Research on Schizophrenia and Depression

National Institutes of Health

Takeda Pharmaceutical Company

BlackThorn Therapeutics

National Institute on Drug Abuse

Agency for Healthcare Research and Quality

Defense Advanced Research Projects Agency

National Institute on Aging

Otsuka Pharmaceutical

BrainCells

Pfizer

ACADIA Pharmaceuticals

GlaxoSmithKline

Abbott Laboratories

Astex Pharmaceuticals

H. Lundbeck A/S

International OCD Foundation

Janssen Pharmaceuticals

McLean Hospital

Medtronic

Sunovion

Tufts University

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7529779

publisherhttps://api.elsevier.com/content/article/PII:S000632232031516X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S000632232031516X?httpAccept=text/plain

https://doi.org/10.1016/j.biopsych.2020.04.009

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529779

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansSertralineBupropionTreatment OutcomeProspective StudiesRewardAdultSelective Serotonin Reuptake InhibitorsMajor Depressive Disorder

Keywords

BiomarkersSertralineReward SensitivitybupropionAntidepressant ResponseFrontostriatal ConnectivityAdultTreatment OutcomeRewardMajor Depressive DisorderHumansProspective StudiesSelective Serotonin Reuptake Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justice